Illustration: Annelise Capossela/Axios
The JPMorgan Health Care Conference ended with more than $10 billion in deal announcements, setting a bullish tone for pharma and biotech M&A in 2024.
Yes, but: There was a notable lack of large-scale deal announcements in any health sector outside of pharma.
